Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894490178> ?p ?o ?g. }
- W2894490178 endingPage "5082" @default.
- W2894490178 startingPage "5066" @default.
- W2894490178 abstract "Abstract Background Tumor‐infiltrating lymphocytes (TILs) have been shown to be of prognostic value in several cancer types. In early breast cancer, TILs have a prognostic utility, as well, especially in HER2‐positive and triple‐negative breast cancer. TILs presence is broadly associated with improved survival; however, there is controversy regarding TILs subpopulations. Patients and methods Early‐stage breast cancer patients treated with anthracycline‐based chemotherapy within two randomized trials were included in the study. We evaluated, by qRT‐PCR, 826 tumor tissue samples for mRNA expression of CD3, CD8, and FOXP3 for potential prognostic significance in terms of disease‐free survival (DFS) and overall survival (OS). Results After a median follow‐up of 133.0 months, 255 patients (30.9%) had died and 314 (38.0%) had disease progression. In the univariate analysis, high CD3 and CD8 mRNA expression was found to be of favorable prognostic value for DFS ( P = 0.007 and P = 0.016, respectively). In multivariate analyses, the association of high CD8 mRNA expression with increased DFS was retained (HR = 0.77, 95% CI 0.60‐0.998, Wald's P = 0.048), whereas that of high CD3 mRNA expression was of marginal statistical significance (HR = 0.77, 95% CI 0.59‐1.01, P = 0.059). Moreover, a significant interaction was observed between HER2 status and CD3 mRNA expression with respect to DFS (interaction P = 0.032). In the HER2‐positive subgroup, the hazard ratio associated with high CD3 mRNA expression was of greater magnitude (HR = 0.48, 95% CI 0.30‐0.76, P = 0.002) compared with the hazard ratio presented above, for the entire cohort. No significant findings were observed for FOXP3 in terms of DFS, while none of the studied markers were of prognostic value for OS. Conclusions High CD3 and CD8 mRNA expression in early‐stage breast cancer patients is of prognostic value for decreased risk of relapse and, in the future, could potentially be of importance in deciding the most appropriate therapeutic strategy in light of the recent immune‐related treatment developments." @default.
- W2894490178 created "2018-10-05" @default.
- W2894490178 creator A5005730021 @default.
- W2894490178 creator A5008841797 @default.
- W2894490178 creator A5012112204 @default.
- W2894490178 creator A5015437737 @default.
- W2894490178 creator A5018787724 @default.
- W2894490178 creator A5026269698 @default.
- W2894490178 creator A5027646786 @default.
- W2894490178 creator A5028178125 @default.
- W2894490178 creator A5041597500 @default.
- W2894490178 creator A5046758725 @default.
- W2894490178 creator A5046824508 @default.
- W2894490178 creator A5047462307 @default.
- W2894490178 creator A5047656028 @default.
- W2894490178 creator A5048322584 @default.
- W2894490178 creator A5053472188 @default.
- W2894490178 creator A5054390455 @default.
- W2894490178 creator A5057164541 @default.
- W2894490178 creator A5062012521 @default.
- W2894490178 creator A5090633646 @default.
- W2894490178 creator A5014959415 @default.
- W2894490178 date "2018-09-21" @default.
- W2894490178 modified "2023-10-14" @default.
- W2894490178 title "Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy" @default.
- W2894490178 cites W1862369714 @default.
- W2894490178 cites W1969960083 @default.
- W2894490178 cites W1978410307 @default.
- W2894490178 cites W1995494263 @default.
- W2894490178 cites W1997083552 @default.
- W2894490178 cites W1999070116 @default.
- W2894490178 cites W2011483165 @default.
- W2894490178 cites W2020016182 @default.
- W2894490178 cites W2027726380 @default.
- W2894490178 cites W2064661384 @default.
- W2894490178 cites W2073718946 @default.
- W2894490178 cites W2085536261 @default.
- W2894490178 cites W2087324367 @default.
- W2894490178 cites W2087565566 @default.
- W2894490178 cites W2087810003 @default.
- W2894490178 cites W2093350606 @default.
- W2894490178 cites W2096864872 @default.
- W2894490178 cites W2098683355 @default.
- W2894490178 cites W2104453868 @default.
- W2894490178 cites W2107380545 @default.
- W2894490178 cites W2109497907 @default.
- W2894490178 cites W2110252240 @default.
- W2894490178 cites W2112434826 @default.
- W2894490178 cites W2112648444 @default.
- W2894490178 cites W2113479349 @default.
- W2894490178 cites W2113499049 @default.
- W2894490178 cites W2117649489 @default.
- W2894490178 cites W2118834968 @default.
- W2894490178 cites W2120338564 @default.
- W2894490178 cites W2120374074 @default.
- W2894490178 cites W2120431466 @default.
- W2894490178 cites W2121626779 @default.
- W2894490178 cites W2129623087 @default.
- W2894490178 cites W2130900820 @default.
- W2894490178 cites W2131091131 @default.
- W2894490178 cites W2134878729 @default.
- W2894490178 cites W2137853125 @default.
- W2894490178 cites W2138523273 @default.
- W2894490178 cites W2140633375 @default.
- W2894490178 cites W2156604663 @default.
- W2894490178 cites W2157058802 @default.
- W2894490178 cites W2157824068 @default.
- W2894490178 cites W2160085908 @default.
- W2894490178 cites W2164654899 @default.
- W2894490178 cites W2167341447 @default.
- W2894490178 cites W2170793099 @default.
- W2894490178 cites W2286651341 @default.
- W2894490178 cites W2340129316 @default.
- W2894490178 cites W2466558384 @default.
- W2894490178 cites W2466867531 @default.
- W2894490178 cites W2474819803 @default.
- W2894490178 cites W2528955977 @default.
- W2894490178 cites W2559561655 @default.
- W2894490178 cites W2588708887 @default.
- W2894490178 cites W2732084179 @default.
- W2894490178 cites W2783304102 @default.
- W2894490178 doi "https://doi.org/10.1002/cam4.1730" @default.
- W2894490178 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6198219" @default.
- W2894490178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30240146" @default.
- W2894490178 hasPublicationYear "2018" @default.
- W2894490178 type Work @default.
- W2894490178 sameAs 2894490178 @default.
- W2894490178 citedByCount "10" @default.
- W2894490178 countsByYear W28944901782020 @default.
- W2894490178 countsByYear W28944901782021 @default.
- W2894490178 countsByYear W28944901782022 @default.
- W2894490178 countsByYear W28944901782023 @default.
- W2894490178 crossrefType "journal-article" @default.
- W2894490178 hasAuthorship W2894490178A5005730021 @default.
- W2894490178 hasAuthorship W2894490178A5008841797 @default.
- W2894490178 hasAuthorship W2894490178A5012112204 @default.
- W2894490178 hasAuthorship W2894490178A5014959415 @default.
- W2894490178 hasAuthorship W2894490178A5015437737 @default.